Pepkon Alternatives & Competitors
12 companies similar to Pepkon — Pioneering breakthrough peptides for treating challenging cancers with precision...
Companies similar to Pepkon
Sapience Therapeutics, Inc.
Changing the Tide to Achieve the Unachievable
Tarrytown, United States
Exelixis
Exelixis works on discovering, developing, and commercializing therapies for the treatment...
Alameda, United States
Cybrexa Therapeutics
Changing the paradigm for cancer treatment through the development of antigen-independent...
New Haven, United States
Avenzo Therapeutics
Developing the next generation of oncology therapies for patients
San Diego, United States
Rival Readout
Competing with Pepkon? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Prelude Therapeutics
Precision Oncology, Redefined.
Wilmington, United States
NBE-Therapeutics AG
Next generation antibody drug conjugates
Basel, Switzerland
FogPharma
Until everything is druggable.
Cambridge, United States
Arcellx
Arcellx is a clinical-stage biotechnology company based in Redwood City, California
Redwood City, United Stat...
Blueprint Medicines
Striving to improve and extend patients' lives
Cambridge, United States
LAVA Therapeutics N.V.
Developing next generation bispecific gamma-delta T cell engaging (bsTCE) antibodies to fi...
Utrecht, The Netherlands
PMV Pharmaceuticals, Inc.
Harnessing the power of p53 to treat cancer
Princeton, United States
Arcus Biosciences
Biopharmaceutical company developing differentiated molecules and combination therapies fo...
Hayward, United States
About Pepkon
Pepkon, with its slogan "Pioneering breakthrough peptides for treating challenging cancers with precision and hope," is a French biotechnology startup established in 2022. The company’s primary focus is on developing first-in-class peptides aimed at treating cancers that are currently considered incurable or have a poo...
Peptide synthesis and testing, Drug optimization, Clinical trial advancement, Academic research collaboration, In-vivo and preclinical studies
Pharmaceutical companies, Biotech researchers, Oncologists, Healthcare institutions, Cancer patients
Cancer Treatment, Peptide Therapeutics, Precision Medicine, First-in-class Drug Development, Leukemia Treatment, Solid Tumors Treatment, Orphan Cancer Therapies, Pediatric Cancer Treatment, Pharmaceutical Research, Clinical Trials, Chronic Lymphocytic Leukemia (CLL), Thrombospondin-1 Peptides, Academic Research Collaboration, Oncology Innovation
B2B, B2D
Licensing, Product Sales, Performance Based
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Pepkon: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Pepkon on 23 Nov 2025. The 12 companies listed here were last checked between 27 Nov 2025 and 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
